Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Nanette Santoro to Menopause

This is a "connection" page, showing publications Nanette Santoro has written about Menopause.

 
Connection Strength
  
 
 
20.409
  
  1. Santoro N, Neal-Perry G, Stute P, Blogg M, Mancuso S, Morga A, Ottery FD, Siddiqui E. Fezolinetant effect on vasomotor symptoms due to menopause in women unsuitable for hormone therapy. Curr Med Res Opin. 2025 Feb; 41(2):375-384.
    View in: PubMed
    Score: 0.768
  2. Green R, Metcalf CA, Santoro N. Mental Well-being in Menopause. Obstet Gynecol Clin North Am. 2025 Mar; 52(1):51-66.
    View in: PubMed
    Score: 0.752
  3. Santoro N. Basics of the menopause transition. Menopause. 2024 Oct 01; 31(10):921-922.
    View in: PubMed
    Score: 0.745
  4. Santoro N. Neurokinin receptor antagonists as potential nonhormone treatments for vasomotor symptoms. Menopause. 2024 Oct 01; 31(10):923-925.
    View in: PubMed
    Score: 0.741
  5. Johnson KA, Martin N, Nappi RE, Neal-Perry G, Shapiro M, Stute P, Thurston RC, Wolfman W, English M, Franklin C, Lee M, Santoro N. Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT. J Clin Endocrinol Metab. 2023 07 14; 108(8):1981-1997.
    View in: PubMed
    Score: 0.685
  6. Santoro N. What's up (or down) with lipids in menopause? Fertil Steril. 2023 06; 119(6):1068.
    View in: PubMed
    Score: 0.670
  7. Santoro N, Flyckt R, Davis A, Finkelstein J, Crawford S, Sun F, Derby C, Morrison A, Sluss P, Zhang H. Anti-M?llerian Hormone Level Decline in Patients Undergoing Hysterectomy With and Without Oophorectomy Compared With Natural Menopause. Obstet Gynecol. 2023 02 01; 141(2):331-340.
    View in: PubMed
    Score: 0.661
  8. Santoro N, Liss J. Compounded Bioidentical Hormones: Myths and Realities. Clin Obstet Gynecol. 2021 12 01; 64(4):793-802.
    View in: PubMed
    Score: 0.613
  9. Santoro N, Roeca C, Peters BA, Neal-Perry G. The Menopause Transition: Signs, Symptoms, and Management Options. J Clin Endocrinol Metab. 2021 01 01; 106(1):1-15.
    View in: PubMed
    Score: 0.575
  10. Finkelstein JS, Lee H, Karlamangla A, Neer RM, Sluss PM, Burnett-Bowie SM, Darakananda K, Donahoe PK, Harlow SD, Prizand SH, Joffe H, Kumar A, Martin DE, McConnell D, Merrilat S, Morrison A, Pastore LM, Randolph JF, Greendale GA, Santoro N. Antimullerian Hormone and Impending Menopause in Late Reproductive Age: The Study of Women's Health Across the Nation. J Clin Endocrinol Metab. 2020 04 01; 105(4).
    View in: PubMed
    Score: 0.546
  11. Santoro N, El Khoudary SR, Nasr A, Gold EB, Greendale G, McConnell D, Neal-Perry G, Pavlovic J, Derby C, Crawford S. Daily luteal serum and urinary hormone profiles in the menopause transition: Study of Women's Health Across the Nation. Menopause. 2020 02; 27(2):127-133.
    View in: PubMed
    Score: 0.539
  12. Allshouse A, Pavlovic J, Santoro N. Menstrual Cycle Hormone Changes Associated with Reproductive Aging and How They May Relate to Symptoms. Obstet Gynecol Clin North Am. 2018 Dec; 45(4):613-628.
    View in: PubMed
    Score: 0.494
  13. Santoro N, Kravitz HM. The Disruptive Changes of Midlife: A Biopsychosocial Adventure. Obstet Gynecol Clin North Am. 2018 12; 45(4):xv-xvii.
    View in: PubMed
    Score: 0.494
  14. Thurston RC, Bhasin S, Chang Y, Barinas-Mitchell E, Matthews KA, Jasuja R, Santoro N. Reproductive Hormones and Subclinical Cardiovascular Disease in Midlife Women. J Clin Endocrinol Metab. 2018 08 01; 103(8):3070-3077.
    View in: PubMed
    Score: 0.486
  15. Santoro N. Feed a hot flash, starve a hot flash? Menopause. 2017 01; 24(1):1-2.
    View in: PubMed
    Score: 0.436
  16. Umland EM, Karel L, Santoro N. Bazedoxifene and Conjugated Equine Estrogen: A Combination Product for the Management of Vasomotor Symptoms and Osteoporosis Prevention Associated with Menopause. Pharmacotherapy. 2016 05; 36(5):548-61.
    View in: PubMed
    Score: 0.417
  17. Grindler NM, Santoro NF. Menopause and exercise. Menopause. 2015 Dec; 22(12):1351-8.
    View in: PubMed
    Score: 0.404
  18. Pinkerton JV, Santoro N. Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women. Menopause. 2015 Sep; 22(9):926-36.
    View in: PubMed
    Score: 0.397
  19. Santoro N, Epperson CN, Mathews SB. Menopausal Symptoms and Their Management. Endocrinol Metab Clin North Am. 2015 Sep; 44(3):497-515.
    View in: PubMed
    Score: 0.397
  20. Santoro N, Pal L. Menopause and Perimenopause. Preface. Endocrinol Metab Clin North Am. 2015 Sep; 44(3):xvii-xviii.
    View in: PubMed
    Score: 0.397
  21. Al-Safi ZA, Santoro N. Menopausal hormone therapy and menopausal symptoms. Fertil Steril. 2014 Apr; 101(4):905-15.
    View in: PubMed
    Score: 0.358
  22. Santoro N, Sutton-Tyrrell K. The SWAN song: Study of Women's Health Across the Nation's recurring themes. Obstet Gynecol Clin North Am. 2011 Sep; 38(3):417-23.
    View in: PubMed
    Score: 0.301
  23. Butler L, Santoro N. The reproductive endocrinology of the menopausal transition. Steroids. 2011 Jun; 76(7):627-35.
    View in: PubMed
    Score: 0.291
  24. Green R, Polotsky AJ, Wildman RP, McGinn AP, Lin J, Derby C, Johnston J, Ram KT, Crandall CJ, Thurston R, Gold E, Weiss G, Santoro N. Menopausal symptoms within a Hispanic cohort: SWAN, the Study of Women's Health Across the Nation. Climacteric. 2010 Aug; 13(4):376-84.
    View in: PubMed
    Score: 0.279
  25. Santoro N, Fan M, Maslow B, Schoenbaum E. Women and HIV infection: the makings of a midlife crisis. Maturitas. 2009 Nov 20; 64(3):160-4.
    View in: PubMed
    Score: 0.263
  26. Green R, Santoro N. Menopausal symptoms and ethnicity: the Study of Women's Health Across the Nation. Womens Health (Lond). 2009 Mar; 5(2):127-33.
    View in: PubMed
    Score: 0.253
  27. Santoro N. Symptoms of menopause: hot flushes. Clin Obstet Gynecol. 2008 Sep; 51(3):539-48.
    View in: PubMed
    Score: 0.245
  28. Santoro N, Crawford SL, Lasley WL, Luborsky JL, Matthews KA, McConnell D, Randolph JF, Gold EB, Greendale GA, Korenman SG, Powell L, Sowers MF, Weiss G. Factors related to declining luteal function in women during the menopausal transition. J Clin Endocrinol Metab. 2008 May; 93(5):1711-21.
    View in: PubMed
    Score: 0.236
  29. Santoro N, Lo Y, Moskaleva G, Arnsten JH, Floris-Moore M, Howard AA, Adel G, Zeitlian G, Schoenbaum EE. Factors affecting reproductive hormones in HIV-infected, substance-using middle-aged women. Menopause. 2007 Sep-Oct; 14(5):859-65.
    View in: PubMed
    Score: 0.228
  30. Santoro N, Brockwell S, Johnston J, Crawford SL, Gold EB, Harlow SD, Matthews KA, Sutton-Tyrrell K. Helping midlife women predict the onset of the final menses: SWAN, the Study of Women's Health Across the Nation. Menopause. 2007 May-Jun; 14(3 Pt 1):415-24.
    View in: PubMed
    Score: 0.223
  31. Niklaus AL, Aubuchon M, Zapantis G, Li P, Qian H, Isaac B, Kim MY, Adel G, Pollard JW, Santoro NF. Assessment of the proliferative status of epithelial cell types in the endometrium of young and menopausal transition women. Hum Reprod. 2007 Jun; 22(6):1778-88.
    View in: PubMed
    Score: 0.221
  32. Santoro N. The menopausal transition. Am J Med. 2005 Dec 19; 118 Suppl 12B:8-13.
    View in: PubMed
    Score: 0.203
  33. Schoenbaum EE, Hartel D, Lo Y, Howard AA, Floris-Moore M, Arnsten JH, Santoro N. HIV infection, drug use, and onset of natural menopause. Clin Infect Dis. 2005 Nov 15; 41(10):1517-24.
    View in: PubMed
    Score: 0.200
  34. Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric. 2005 Mar; 8(1):3-12.
    View in: PubMed
    Score: 0.192
  35. Santoro N, Chervenak JL. The menopause transition. Endocrinol Metab Clin North Am. 2004 Dec; 33(4):627-36.
    View in: PubMed
    Score: 0.189
  36. Santoro N, Lasley B, McConnell D, Allsworth J, Crawford S, Gold EB, Finkelstein JS, Greendale GA, Kelsey J, Korenman S, Luborsky JL, Matthews K, Midgley R, Powell L, Sabatine J, Schocken M, Sowers MF, Weiss G. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study. J Clin Endocrinol Metab. 2004 Jun; 89(6):2622-31.
    View in: PubMed
    Score: 0.182
  37. Shapiro C M M, Cano A, Nappi RE, Santoro N, English ML, Mancuso S, Morga A, Siddiqui E, Valluri U, Ottery FD. Effect of fezolinetant on sleep disturbance and impairment during treatment of vasomotor symptoms due to menopause. Maturitas. 2024 Aug; 186:107999.
    View in: PubMed
    Score: 0.182
  38. Santoro N, Nappi RE, Neal-Perry G, English M, King DD, Yamaguchi Y, Ottery FD. Fezolinetant treatment of moderate-to-severe vasomotor symptoms due to menopause: effect of intrinsic and extrinsic factors in two phase 3 studies (SKYLIGHT 1 and 2). Menopause. 2024 Apr 01; 31(4):247-257.
    View in: PubMed
    Score: 0.180
  39. Cano A, Nappi RE, Santoro N, Stute P, Blogg M, English ML, Morga A, Scrine L, Siddiqui E, Ottery FD. Fezolinetant impact on health-related quality of life for vasomotor symptoms due to the menopause: Pooled data from SKYLIGHT 1 and SKYLIGHT 2 randomised controlled trials. BJOG. 2024 Aug; 131(9):1296-1305.
    View in: PubMed
    Score: 0.178
  40. Berga SL, Merkison J, Schirmer DA, Kawwass JF, Santoro N. Should menopause care be part of the skill set of a reproductive endocrinology and infertility specialist? Fertil Steril. 2024 02; 121(2):213-218.
    View in: PubMed
    Score: 0.176
  41. Liss J, Pettigrew J, Santoro N. Type and age of menopause: potential implications for female sexual health. J Sex Med. 2023 06 28; 20(7):921-924.
    View in: PubMed
    Score: 0.171
  42. Zapantis G, Santoro N. The menopausal transition: characteristics and management. Best Pract Res Clin Endocrinol Metab. 2003 Mar; 17(1):33-52.
    View in: PubMed
    Score: 0.167
  43. Hickey M, Hunter MS, Santoro N, Ussher J. Normalising menopause. BMJ. 2022 06 15; 377:e069369.
    View in: PubMed
    Score: 0.159
  44. Santoro N. The menopause transition: an update. Hum Reprod Update. 2002 Mar-Apr; 8(2):155-60.
    View in: PubMed
    Score: 0.156
  45. Peters BA, Xue X, Sheira LA, Qi Q, Sharma A, Santoro N, Alcaide ML, Ofotokun I, Adimora AA, McKay HS, Tien PC, Michel KG, Gustafson D, Turan B, Landay AL, Kaplan RC, Weiser SD. Menopause Is Associated With Immune Activation in Women With HIV. J Infect Dis. 2022 01 18; 225(2):295-305.
    View in: PubMed
    Score: 0.155
  46. Marlatt KL, Pitynski-Miller DR, Gavin KM, Moreau KL, Melanson EL, Santoro N, Kohrt WM. Body composition and cardiometabolic health across the menopause transition. Obesity (Silver Spring). 2022 01; 30(1):14-27.
    View in: PubMed
    Score: 0.154
  47. Kracht CL, Romain JS, Hardee JC, Santoro N, Redman LM, Marlatt KL. "It just seems like people are talking about menopause, but nobody has a solution": A qualitative exploration of menopause experiences and preferences for weight management among Black women. Maturitas. 2022 03; 157:16-26.
    View in: PubMed
    Score: 0.152
  48. El Khoudary SR, Qi M, Chen X, Matthews K, Allshouse AA, Crawford SL, Derby CA, Thurston RC, Kazlauskaite R, Barinas-Mitchell E, Santoro N. Patterns of menstrual cycle length over the menopause transition are associated with subclinical atherosclerosis after menopause. Menopause. 2021 10 11; 29(1):8-15.
    View in: PubMed
    Score: 0.152
  49. Lersten I, Clain E, Santoro N. Use of Hormone Therapy in Women with Early Menopause and Premature Ovarian Insufficiency. Semin Reprod Med. 2020 09; 38(4-05):302-308.
    View in: PubMed
    Score: 0.145
  50. Santoro N, Waldbaum A, Lederman S, Kroll R, Fraser GL, Lademacher C, Skillern L, Young J, Ramael S. Effect of the neurokinin 3 receptor antagonist fezolinetant on patient-reported outcomes in postmenopausal women with vasomotor symptoms: results of a randomized, placebo-controlled, double-blind, dose-ranging study (VESTA). Menopause. 2020 12; 27(12):1350-1356.
    View in: PubMed
    Score: 0.143
  51. Pinkerton JV, Faubion SS, Kaunitz AM, Liu JH, Manson JE, Santoro NF, Shifren JL, Stuenkel CA. The National Academies of Science, Engineering, and Medicine (NASEM) Report on Compounded Bioidentical Hormone Therapy. Menopause. 2020 11; 27(11):1199-1201.
    View in: PubMed
    Score: 0.142
  52. Stuenkel CA, Santoro NF, Laughlin-Tommaso SK, Black A, Joffe H, Su HI. NAMS 2019 Pre-Meeting Symposium, September 2019, Chicago Illinois: The Perimenopause. Menopause. 2020 07; 27(7):735-745.
    View in: PubMed
    Score: 0.139
  53. Fraser GL, Lederman S, Waldbaum A, Kroll R, Santoro N, Lee M, Skillern L, Ramael S. A phase 2b, randomized, placebo-controlled, double-blind, dose-ranging study of the neurokinin 3 receptor antagonist fezolinetant for vasomotor symptoms associated with menopause. Menopause. 2020 04; 27(4):382-392.
    View in: PubMed
    Score: 0.136
  54. Miller VM, Naftolin F, Asthana S, Black DM, Brinton EA, Budoff MJ, Cedars MI, Dowling NM, Gleason CE, Hodis HN, Jayachandran M, Kantarci K, Lobo RA, Manson JE, Pal L, Santoro NF, Taylor HS, Harman SM. The Kronos Early Estrogen Prevention Study (KEEPS): what have we learned? Menopause. 2019 09; 26(9):1071-1084.
    View in: PubMed
    Score: 0.131
  55. Santoro N, Banwell T, Tortoriello D, Lieman H, Adel T, Skurnick J. Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women. Am J Obstet Gynecol. 1998 Apr; 178(4):732-41.
    View in: PubMed
    Score: 0.119
  56. Cintron D, Lahr BD, Bailey KR, Santoro N, Lloyd R, Manson JE, Neal-Perry G, Pal L, Taylor HS, Wharton W, Naftolin F, Harman SM, Miller VM. Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). Menopause. 2018 02; 25(2):145-153.
    View in: PubMed
    Score: 0.117
  57. Paramsothy P, Harlow SD, Nan B, Greendale GA, Santoro N, Crawford SL, Gold EB, Tepper PG, Randolph JF. Duration of the menopausal transition is longer in women with young age at onset: the multiethnic Study of Women's Health Across the Nation. Menopause. 2017 02; 24(2):142-149.
    View in: PubMed
    Score: 0.110
  58. Thurston RC, Chang Y, von K?nel R, Barinas-Mitchell E, Jennings JR, Hall MH, Santoro N, Buysse DJ, Matthews KA. Sleep Characteristics and Carotid Atherosclerosis Among Midlife Women. Sleep. 2017 Feb 01; 40(2).
    View in: PubMed
    Score: 0.110
  59. El Khoudary SR, Santoro N, Chen HY, Tepper PG, Brooks MM, Thurston RC, Janssen I, Harlow SD, Barinas-Mitchell E, Selzer F, Derby CA, Jackson EA, McConnell D, Matthews KA. Trajectories of estradiol and follicle-stimulating hormone over the menopause transition and early markers of atherosclerosis after menopause. Eur J Prev Cardiol. 2016 May; 23(7):694-703.
    View in: PubMed
    Score: 0.100
  60. Davis SR, Lambrinoudaki I, Lumsden M, Mishra GD, Pal L, Rees M, Santoro N, Simoncini T. Menopause. Nat Rev Dis Primers. 2015 04 23; 1:15004.
    View in: PubMed
    Score: 0.097
  61. Allshouse AA, Semple AL, Santoro NF. Evidence for prolonged and unique amenorrhea-related symptoms in women with premature ovarian failure/primary ovarian insufficiency. Menopause. 2015 Feb; 22(2):166-74.
    View in: PubMed
    Score: 0.095
  62. Polotsky AJ, Allshouse AA, Crawford SL, Harlow SD, Khalil N, Kazlauskaite R, Santoro N, Legro RS. Hyperandrogenic oligomenorrhea and metabolic risks across menopausal transition. J Clin Endocrinol Metab. 2014 Jun; 99(6):2120-7.
    View in: PubMed
    Score: 0.089
  63. Wildman RP, Tepper PG, Crawford S, Finkelstein JS, Sutton-Tyrrell K, Thurston RC, Santoro N, Sternfeld B, Greendale GA. Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from the Study of Women's Health Across the Nation. J Clin Endocrinol Metab. 2012 Sep; 97(9):E1695-704.
    View in: PubMed
    Score: 0.080
  64. Polotsky AJ, Allshouse A, Crawford SL, Harlow SD, Khalil N, Santoro N, Legro RS. Relative contributions of oligomenorrhea and hyperandrogenemia to the risk of metabolic syndrome in midlife women. J Clin Endocrinol Metab. 2012 Jun; 97(6):E868-77.
    View in: PubMed
    Score: 0.078
  65. Santoro N. Update in hyper- and hypogonadotropic amenorrhea. J Clin Endocrinol Metab. 2011 Nov; 96(11):3281-8.
    View in: PubMed
    Score: 0.076
  66. Zhang K, Zeitlian G, Adel G, Santoro NF, Pal L. Enhanced hypothalamic-pituitary sensitivity to estrogen in premenopausal women with diminished ovarian reserve compared with older perimenopausal controls. Menopause. 2011 Aug; 18(8):880-5.
    View in: PubMed
    Score: 0.075
  67. Lipton LR, Santoro N, Taylor H, Kidwai N, Isaac B, Magnani M, Pal L. Assessing comprehension of clinical research. Contemp Clin Trials. 2011 Sep; 32(5):608-13.
    View in: PubMed
    Score: 0.074
  68. Crawford S, Santoro N, Laughlin GA, Sowers MF, McConnell D, Sutton-Tyrrell K, Weiss G, Vuga M, Randolph J, Lasley B. Circulating dehydroepiandrosterone sulfate concentrations during the menopausal transition. J Clin Endocrinol Metab. 2009 Aug; 94(8):2945-51.
    View in: PubMed
    Score: 0.064
  69. Fan MD, Maslow BS, Santoro N, Schoenbaum E. HIV and the menopause. Menopause Int. 2008 Dec; 14(4):163-8.
    View in: PubMed
    Score: 0.062
  70. Hartel D, Lo Y, Bauer C, Budner N, Howard AA, Floris-Moore M, Arnsten JH, Santoro N, Schoenbaum EE. Attitudes toward menopause in HIV-infected and at-risk women. Clin Interv Aging. 2008; 3(3):561-6.
    View in: PubMed
    Score: 0.058
  71. Johnston JM, Colvin A, Johnson BD, Santoro N, Harlow SD, Bairey Merz CN, Sutton-Tyrrell K. Comparison of SWAN and WISE menopausal status classification algorithms. J Womens Health (Larchmt). 2006 Dec; 15(10):1184-94.
    View in: PubMed
    Score: 0.054
  72. Wierman ME, Basson R, Davis SR, Khosla S, Miller KK, Rosner W, Santoro N. Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab. 2006 Oct; 91(10):3697-710.
    View in: PubMed
    Score: 0.054
  73. Matthews KA, Santoro N, Lasley B, Chang Y, Crawford S, Pasternak RC, Sutton-Tyrrell K, Sowers M. Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases. J Clin Endocrinol Metab. 2006 May; 91(5):1789-95.
    View in: PubMed
    Score: 0.051
  74. Powell LH, Meyer P, Weiss G, Matthews KA, Santoro N, Randolph JF, Schocken M, Skurnick J, Ory MG, Sutton-Tyrrell K. Ethnic differences in past hysterectomy for benign conditions. Womens Health Issues. 2005 Jul-Aug; 15(4):179-86.
    View in: PubMed
    Score: 0.049
  75. Mitro SD, Waetjen LE, Lee C, Wise LA, Zaritsky E, Harlow SD, El Khoudary SR, Santoro N, Solomon DH, Thurston RC, Hedderson MM. Diabetes and Uterine Fibroid Diagnosis in Midlife: Study of Women's Health Across the Nation (SWAN). J Clin Endocrinol Metab. 2025 May 19; 110(6):e1934-e1942.
    View in: PubMed
    Score: 0.049
  76. Miller SA, Santoro N, Lo Y, Howard AA, Arnsten JH, Floris-Moore M, Moskaleva G, Schoenbaum EE. Menopause symptoms in HIV-infected and drug-using women. Menopause. 2005 May-Jun; 12(3):348-56.
    View in: PubMed
    Score: 0.049
  77. Santoro N, Torrens J, Crawford S, Allsworth JE, Finkelstein JS, Gold EB, Korenman S, Lasley WL, Luborsky JL, McConnell D, Sowers MF, Weiss G. Correlates of circulating androgens in mid-life women: the study of women's health across the nation. J Clin Endocrinol Metab. 2005 Aug; 90(8):4836-45.
    View in: PubMed
    Score: 0.048
  78. Kara F, Tosakulwong N, Lesnick TG, Fought AJ, Kendell-Thomas J, Kapoor E, Faubion LL, Schwarz CG, Senjem ML, Fields JA, Min PH, Lowe VJ, Jack CR, Bailey KR, James TT, Lobo RA, Manson JE, Pal L, Hammers DB, Malek-Ahmadi M, Cedars MI, Naftolin FN, Santoro N, Miller VM, Harman SM, Dowling NM, Gleason CE, Kantarci K. Associations of blood pressure with white matter hyperintensities later in life; influence of short-term menopausal hormone therapy. Menopause. 2025 Jan 01; 32(1):12-22.
    View in: PubMed
    Score: 0.047
  79. Weiss G, Skurnick JH, Goldsmith LT, Santoro NF, Park SJ. Menopause and hypothalamic-pituitary sensitivity to estrogen. JAMA. 2004 Dec 22; 292(24):2991-6.
    View in: PubMed
    Score: 0.047
  80. Torr?ns JI, Skurnick J, Davidow AL, Korenman SG, Santoro N, Soto-Greene M, Lasser N, Weiss G. Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN). Diabetes Care. 2004 Feb; 27(2):354-61.
    View in: PubMed
    Score: 0.044
  81. Santoro N, Isaac B, Neal-Perry G, Adel T, Weingart L, Nussbaum A, Thakur S, Jinnai H, Khosla N, Barad D. Impaired folliculogenesis and ovulation in older reproductive aged women. J Clin Endocrinol Metab. 2003 Nov; 88(11):5502-9.
    View in: PubMed
    Score: 0.044
  82. Kracht CL, St Romain J, Hardee JC, Santoro N, Redman LM, Marlatt KL. "Weight loss is my goal and being healthy is my goal? I can get over the hot flashes": a qualitative exploration of menopausal transition experiences and preferences for weight management among White women. Menopause. 2023 10 01; 30(10):1022-1032.
    View in: PubMed
    Score: 0.043
  83. Davis SR, Pinkerton J, Santoro N, Simoncini T. Menopause-Biology, consequences, supportive care, and therapeutic options. Cell. 2023 09 14; 186(19):4038-4058.
    View in: PubMed
    Score: 0.043
  84. Randolph JF, Sowers M, Gold EB, Mohr BA, Luborsky J, Santoro N, McConnell DS, Finkelstein JS, Korenman SG, Matthews KA, Sternfeld B, Lasley BL. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab. 2003 Apr; 88(4):1516-22.
    View in: PubMed
    Score: 0.042
  85. Santoro N. Mechanisms of premature ovarian failure. Ann Endocrinol (Paris). 2003 Apr; 64(2):87-92.
    View in: PubMed
    Score: 0.042
  86. Lederman S, Ottery FD, Cano A, Santoro N, Shapiro M, Stute P, Thurston RC, English M, Franklin C, Lee M, Neal-Perry G. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lancet. 2023 04 01; 401(10382):1091-1102.
    View in: PubMed
    Score: 0.042
  87. Neal-Perry G, Cano A, Lederman S, Nappi RE, Santoro N, Wolfman W, English M, Franklin C, Valluri U, Ottery FD. Safety of Fezolinetant for Vasomotor Symptoms Associated With Menopause: A Randomized Controlled Trial. Obstet Gynecol. 2023 04 01; 141(4):737-747.
    View in: PubMed
    Score: 0.042
  88. Christmas M, Janssen I, Joffe H, Upchurch D, Santoro N, Kravitz HM. Menopause hormone therapy and complementary alternative medicine, quality of life, and racial/ethnic differences: the Study of Women's Health Across the Nation (SWAN). Menopause. 2022 12 01; 29(12):1357-1364.
    View in: PubMed
    Score: 0.041
  89. Lasley BL, Santoro N, Randolf JF, Gold EB, Crawford S, Weiss G, McConnell DS, Sowers MF. The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab. 2002 Aug; 87(8):3760-7.
    View in: PubMed
    Score: 0.040
  90. Pal L, Morgan K, Santoro NF, Manson JE, Taylor HS, Miller VM, Brinton EA, Lobo R, Neal-Perry G, Cedars MI, Harman SM, James TT, Gleason CE. Cardiometabolic measures and cognition in early menopause - Analysis of baseline data from a randomized controlled trial. Maturitas. 2022 08; 162:58-65.
    View in: PubMed
    Score: 0.039
  91. Peters BA, Lin J, Qi Q, Usyk M, Isasi CR, Mossavar-Rahmani Y, Derby CA, Santoro N, Perreira KM, Daviglus ML, Kominiarek MA, Cai J, Knight R, Burk RD, Kaplan RC. Menopause Is Associated with an Altered Gut Microbiome and Estrobolome, with Implications for Adverse Cardiometabolic Risk in the Hispanic Community Health Study/Study of Latinos. mSystems. 2022 06 28; 7(3):e0027322.
    View in: PubMed
    Score: 0.039
  92. Peters BA, Xue X, Wang Z, Usyk M, Santoro N, Sharma A, Anastos K, Tien PC, Golub ET, Weber KM, Gustafson D, Kaplan RC, Burk R, Qi Q. Menopausal status and observed differences in the gut microbiome in women with and without HIV infection. Menopause. 2021 01 11; 28(5):491-501.
    View in: PubMed
    Score: 0.036
  93. Pinkerton JV, Liu JH, Santoro NF, Thurston RC, Joffe H, Faubion SS, Manson JE. Workshop on normal reference ranges for estradiol in postmenopausal women: commentary from The North American Menopause Society on low-dose vaginal estrogen therapy labeling. Menopause. 2020 06; 27(6):611-613.
    View in: PubMed
    Score: 0.035
  94. Owen CM, Pal L, Mumford SL, Freeman R, Isaac B, McDonald L, Santoro N, Taylor HS, Wolff EF. Effects of hormones on skin wrinkles and rigidity vary by race/ethnicity: four-year follow-up from?the ancillary skin study of the Kronos Early Estrogen Prevention Study. Fertil Steril. 2016 Oct; 106(5):1170-1175.e3.
    View in: PubMed
    Score: 0.026
  95. Pavlovic JM, Allshouse AA, Santoro NF, Crawford SL, Thurston RC, Neal-Perry GS, Lipton RB, Derby CA. Sex hormones in women with and without migraine: Evidence of migraine-specific hormone profiles. Neurology. 2016 Jul 05; 87(1):49-56.
    View in: PubMed
    Score: 0.026
  96. Thurston RC, Santoro N, Matthews KA. Adiposity and hot flashes in midlife women: a modifying role of age. J Clin Endocrinol Metab. 2011 Oct; 96(10):E1588-95.
    View in: PubMed
    Score: 0.019
  97. Sutton-Tyrrell K, Zhao X, Santoro N, Lasley B, Sowers M, Johnston J, Mackey R, Matthews K. Reproductive hormones and obesity: 9 years of observation from the Study of Women's Health Across the Nation. Am J Epidemiol. 2010 Jun 01; 171(11):1203-13.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)